Authoritative Analytical CRO & CDMO Ecosystem

China HPLC Chromatography Manufacturer & Supplier

Delivering industry-grade High-Performance Liquid Chromatography (HPLC) analytical validation, complex botanical phytochemical separation, and cGMP-compliant CDMO services backed by over 14 years of peer-recognized chemical assay development.

USP / EP / ChP Compendial Verification 21 CFR Part 11 Data Integrity Pilot-to-Industrial CDMO Scale
Core Solutions Suite

Chromatography & Analytical Development Services

Discover turnkey R&D, clinical trial execution, active ingredient screening, and custom chromatographic analytical method development services.

OEM Animal study Supplier Suppliers

Animal Pharmacology Studies

In vivo efficacy screening, metabolic profiling, and toxicity tracking utilizing advanced chromatographic biospecimen profiling.

OEM Animal study Supplier, Suppliers
Technical Whitepaper Depth

Chromatographic Science & Analytical Method Architecture

Addressing the strict chemical quantification demands of global regulatory bodies through robust liquid chromatography and stationary-phase engineering.

Analytical Method Validation Framework (ICH Q2(R1) Standards)

In the characterization of complex biological matrices and multi-component Traditional Chinese Medicine (TCM) compounds, chromatographic stability and resolution represent the foundation of quality assurance. MedGence applies systematic High-Performance Liquid Chromatography (HPLC) and Ultra-High Performance Liquid Chromatography (UHPLC) coupled with Photodiode Array (PDA), Evaporative Light Scattering Detectors (ELSD), and Triple Quadrupole Mass Spectrometry (LC-MS/MS) to establish empirical quality indices.

  • System Suitability & Resolution: Routine column selectivity calibration ensures critical pairs maintain resolution factors (Rs) greater than 1.5, precluding co-elution anomalies in active multi-glycoside profiles.
  • Limit of Detection (LOD) & Limit of Quantitation (LOQ): Signal-to-noise ratios are held strictly at 3:1 and 10:1 respectively, enabling micro-trace residue monitoring for pesticides, mycotoxins, and heavy metal chelates.
  • Orthogonal Method Testing: Correlating reversed-phase HPLC (RP-HPLC) with High-Performance Thin-Layer Chromatography (HPTLC) fingerprinting delivers 360-degree chromatographic authentication for complete regulatory dossiers.

Industrial Stationary Phase & Preparative Column Dynamics

Scaling analytical methods to industrial contract manufacturing demands linear stationary phase translation. Our manufacturing engineering group integrates analytical column chemistry (sub-2-micron to 5-micron C18, C8, HILIC, and chiral packings) directly with preparative high-pressure stainless steel columns up to 1000 mm diameter. This eliminates peak splitting and band broadening across pilot-scale extractions and commercial batch crystallizations.

14+
Years Specialized Natural Medicine R&D
300+
Research Scientists & Analytical Chemists
~400
Single-Herb Validated Monographs Established
83
Classic Formula Fingerprints Modernized
Sourcing Science & Factory Advantage

China Factory Supply Chain & Global Procurement Hub

Bridging domestic botanical agricultural biodiversity with internationally validated pharmaceutical-grade industrial production capacity.

Direct Agricultural Sourcing

Eliminate secondary broker layers. Our facilities coordinate directly with GAP-certified domestic agricultural origins across Hunan, Sichuan, Yunnan, and Guizhou, mapping seasonal potency variances directly to chromatographic yield specs.

Cost-Efficiency at CDMO Scale

Benefit from vertically integrated infrastructure. From automated continuous countercurrent solvent extractors to automated high-capacity HPLC verification labs, manufacturing overheads drop by 30–45% compared to Western counterparts.

Global Regulatory Compliance

We supply complete Common Technical Document (CTD) analytical dossiers. Every batch export is matched with verifiable Certificates of Analysis (COA), HPLC chromatograms, heavy metal screenings, and stability protocols complying with US FDA, EMA, and NMPA standards.

Technological Trajectory

Industry Trends: The Next Era of Smart Chromatography

Discover how intelligent automation, 2D-HPLC, and green analytical chemistry are transforming botanical active development and manufacturing efficiency.

Comprehensive 2D-HPLC

Orthogonal chromatographic systems (combining non-aqueous reversed phase with hydrophilic interaction chromatography) resolve isomeric complexes that traditional one-dimensional systems miss.

AI Peak Deconvolution

Applying neural networks to real-time UV and Mass Spec elutions isolates overlapping active fractions, predicting stability profiles and shortening method validation cycles by 60%.

Green Chromatography

Transitioning from hazardous chlorinated solvents to Supercritical Fluid Chromatography (SFC) and ethanol-water gradients, reducing carbon emissions and regulatory solvent residue hazards.

Process Analytical Technology

Integrating inline automated HPLC probes with commercial extraction lines to monitor concentration curves instantly, enabling closed-loop feedback and zero batch failures.

Commercial Market Integration

Localized Application Scenarios & Global Industry Alignment

Tailoring chromatographic specifications to market-specific compliance profiles, consumer labeling requirements, and operational safety limits.

North America (Dietary Supplements)

Designed for FDA 21 CFR Part 111 dietary supplement rules. Methods verify exact potency claims on Supplement Facts panels, identify potential adulterants, and validate stability across real-time shelf life.

European Union (EMA / Herbal Monographs)

Methods calibrated to European Pharmacopoeia (Ph. Eur.) criteria. Focuses on total chromatographic fingerprint comparability, low pyrrolizidine alkaloid (PA) detection, and pesticide residue limits (EC 396/2005).

Global Clean-Label Cosmeceuticals

Quantitative evaluation of botanical bioactives (such as glabridin, resveratrol, and madecassoside) for skincare formulations, ensuring solvent-free residual guarantees and batch color stability.

Validated Track Record

Trusted by Industry Leaders & Hospital Centers

Over 100 top-tier pharmaceutical conglomerates, research institutions, and university medical hospitals rely on our R&D and analytical execution.

Beijing Tongrentang Group Tongrentang Group
China Resources Sanjiu CR Sanjiu
Sunflower Pharmaceutical Sunflower Pharma
Livzon Pharmaceutical Livzon Group
Dihon Pharmaceutical Dihon Pharma
Golden Throat Group Golden Throat
Yangtzi River Pharmaceutical Yangtze River Pharma
Beihai Gofar Chuanshan Biological Gofar Chuanshan
Humanwell Healthcare Humanwell Healthcare
SCIMYTH Pharmaceutical SCIMYTH Pharma
Shandong Hanfang Pharmaceutical Hanfang Pharma
Luoxin Pharmaceutical Luoxin Pharma
Zhongsheng Pharmaceutical Zhongsheng Pharma
Brilliance & Abundance Brilliance & Abundance
Apeloa Pharmaceutical Apeloa Pharma
Heng Chang Pharmaceutical Heng Chang Pharma
Baotou Traditional Chinese Medicine Baotou TCM
Kamp Medicine Kamp Medicine
Santo Pharmaceutical Santo Pharma
Kangshou Pharmaceutical Kangshou Pharma
Juwang Pharmaceutical Juwang Pharma
Tcmages Pharmaceutical Tcmages Pharma
Ruihe Pharmaceutical Ruihe Pharma
Jinchan Pharmaceutical Jinchan Pharma
Kangmei Pharmaceutical Kangmei Pharma
Tianjicaotang Pharmaceutical Tianjicaotang Pharma
Kingstone Unite Pharmaceutical Kingstone Unite
Shuguang Hospital Shuguang Hospital
Hunan TCM Hospital Hunan Prov. TCM Hospital
First Hospital of Hunan TCM First Hospital Hunan TCM
Second Xiangya Hospital Second Xiangya Hospital
Second Hospital of Hunan TCM Second Hospital Hunan TCM
Zhuzhou Orthopedics of TCM Zhuzhou Orthopedics TCM
Technical & Sourcing Inquiries

Frequently Asked Technical & Sourcing Questions

Clear, expert responses to support scientific review, regulatory audits, and international procurement evaluation.

What specific capabilities differentiate MedGence from traditional HPLC equipment manufacturers and chemical trading houses?
Unlike generic equipment vendors who only assemble column hardware, or export merchants who simply warehouse powders, MedGence functions as an integrated R&D CRO and specialized CDMO. We engineer proprietary chromatographic methods, validate compendial standards (HPLC, HPTLC, GC-MS, LC-MS/MS), run in-house cell and animal trials, and directly supervise pilot-to-commercial extraction batches across partner and pilot facilities. We supply the physical validated chemical extract alongside complete regulatory documentation.
How do your chromatographic method establishment services satisfy FDA / EMA audit requirements?
Every analytical protocol developed in our laboratories adheres strictly to ICH Q2(R1) guidelines, covering precision (repeatability and intermediate precision), specificity, linearity (r² > 0.999), limits of detection and quantitation, and forced degradation robustness testing. All data generation complies with 21 CFR Part 11 requirements, featuring non-editable audit trails, secure raw data archiving, and fully traceable reference standards.
How does MedGence handle batch variation and seasonal changes in raw botanical harvests?
Botanical potency changes across harvesting seasons, microclimates, and regional soils. We maintain a proprietary fingerprint database of hundreds of thousands of research batches. By applying HPLC chromatographic fingerprint matching and multivariable principal component analysis (PCA), we optimize harvest timing and blending ratios, ensuring commercial extract deliveries maintain consistent active compound levels without synthetic spiking.
Can intellectual property (IP), proprietary formulas, and purification methods be protected?
Yes. All projects operate under strict bilateral Non-Disclosure Agreements (NDAs) and entrusted development frameworks. Your target bioactives, column elution profiles, synthesis routes, and formulation parameters remain your exclusive intellectual property. Production cells within our collaborative and pilot facilities are segregated, with digital audit access restricted to your designated team.
What dosage formats and bulk finished ingredient physical states are available for global export?
Active ingredients can be isolated and supplied as customized concentrated liquids, crystalline/spray-dried extract powders, viscous pastes, or steam-distilled volatile oils. Our finished dosage CDMO units produce oral liquids, hard-gelatin or vegetable capsules, softgels, micro-tablets, effervescent powders, and vacuum-granulated sachets conforming to cGMP standards.
Does your scientific team support Clinical Studies and Investigational New Drug (IND/NDA) filings?
Yes. We manage small-cohort human bioavailability studies for dietary brand claims, as well as formal GCP-monitored Phase I, Phase II, Phase III, and Phase IV post-market clinical evaluations. Our biostatisticians and medical writers generate comprehensive clinical study reports (CSRs) configured directly for New Drug Application (NDA) submissions and global health agency reviews.
Technical Capabilities Roster

End-to-End Method Development & Manufacturing Pipeline

From raw botanicals to shelf-ready commercial releases, select the operational service package that aligns with your timeline and target markets.

Accelerate Your Pipeline

Consult with Our Senior Analytical & CDMO Scientists

Whether establishing an orthogonal HPLC method for a novel botanical active, verifying compendial USP/EP monograph parameters, or scaling up to multi-ton contract manufacturing, our team delivers the data-backed assurance your business requires.

Submit Technical Project Brief ([email protected]) Schedule Scientific Discovery Call